Multicenter study of combination therapy using calcineurin inhibitor, basiliximab, mizoribine and steroids in kidney transplantation.
Not Applicable
- Conditions
- Kidney transplantation
- Registration Number
- JPRN-UMIN000008751
- Lead Sponsor
- Study group on a multi-drug combination therapy for renal transplantation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1. The patient who has a history of hypersensitivity against components of either one of this study drugs. 2. The patient who has leucopenia. 3. The patient who is pregnant or a female patient who is expecting to become pregnant. 4. The patients who showed a positive result with cross match test. 5. The patient who recived ABO incompatible donor. 6. The patient with whom the physician-in-charge considered inappropriate as a subject of this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method